Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × obinutuzumab × 1 year × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 42 Lymphoma, Follicular 23 Lymphoma, Non-Hodgkin 17 Lymphoma, Large B-Cell, Diffuse 12 Lymphoma 12 Lymphoma, Mantle-Cell 11 Lymphoma, B-Cell, Marginal Zone 11 Recurrence 8 Lymphoma, B-Cell 7 Neoplasms 6 Burkitt Lymphoma 5 Neoplasm, Residual 3 Leukemia, Hairy Cell 3 Leukemia, B-Cell 2 Leukemia 2 Waldenstrom Macroglobulinemia 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Part1: Advanced B-cell Malignancies 1 Ovarian Neoplasms 1 Mycosis Fungoides 1 Mesothelioma 1 Melanoma 1 Mature B-cell Malignancies 1 Lymphoma, T-Cell, Cutaneous 1 Lymphatic Diseases 1 Leukemia, Prolymphocytic 1 Hodgkin Disease 1

Interventions

pembrolizumab 38 Gemcitabine 20 enfortumab vedotin 19 Cisplatin 17 Nivolumab 16 atezolizumab 14 Magnetic Resonance Spectroscopy 14 avelumab 13 Carboplatin 12 Specimen Handling 10 Docetaxel 10 sacituzumab govitecan 9 Paclitaxel 7 Ipilimumab 7 Fluorodeoxyglucose F18 5 pemigatinib 4 toripalimab 3 erdafitinib 3 durvalumab 3 cabozantinib 3 X-Rays 3 Taxes 3 Mitomycin 3 Immunoglobulin G 3 CTLA-4 Antigen 3 Biopsy 3 tislelizumab 2 lenvatinib 2 eribulin 2 dodecyl maltoside 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡